The most significant variant associated with MPM survival was rs6695772 (additive model: HR = 3.42; 95% CI = 1.57–7.42; p = 0.0019; dominant model: HR = 18.69; 95% CI = 3.34–104.55; p = 0.0009) (Fig. 2), linked to the expression of BATF3, which was the same ieQTL predictive of melanoma survival in our recent study25, with the alternate allele of rs6695772 linked to the decreased expression of BATF3 in LCLs (Fig. 1). The gene discussed is BATF3; the disease is melanoma.